NDUFS7: A Potential Drug Target and Mitochondrial Respiratory Chain Enzyme

Target Name: NDUFS7

NCBI ID: G374291

NDUFS7

NDUFS7: A Potential Drug Target and Mitochondrial Respiratory Chain Enzyme

The mitochondria are essential organelles that play a crucial role in the cell's energy metabolism. They are the powerhouses of the cell, where energy production occurs during the process of cellular respiration. Mitochondria are also responsible for maintaining the cell's homeostasis and for regulating various cellular processes. One of the key components of the mitochondrial respiratory chain is the Complex I, which is a protein complex that plays a vital role in the electron transport process.NDUFS7, a gene encoding for the protein 20-KD subunit of Complex I, has been identified as a potential drug target and biomarker for various diseases.

The Complex I subunit is a key component of the mitochondrial respiratory chain, which is a protein complex that transports electrons from the cytoplasm to the mitochondrial matrix during the process of cellular respiration. The Complex I subunit is a 20-kDa protein that is composed of multiple domains, including an N-terminus, a catalytic domain, and a C-terminus. The N-terminus of the protein is involved in the formation of the protein-protein interaction, while the catalytic domain is responsible for the electrochemical reaction that occurs during the electron transport process.

The Complex I subunit has been shown to play a crucial role in various cellular processes, including the production of ATP, the regulation of cellular respiration, and the control of the levels of reactive oxygen species (ROS) in the cell. It is also involved in the transfer of electrons from the cytoplasm to the mitochondrial matrix, which is critical for the production of ATP through the process of cellular respiration.

As a potential drug target, NDUFS7 can be targeted by small molecules or antibodies that can modulate the activity of the Complex I subunit. Such modifications in the protein's activity can lead to changes in the cellular response to various stimuli, including the levels of ATP production, the production of ROS, and the regulation of cellular respiration.

In addition to its role in cellular respiration, NDUFS7 is also involved in the regulation of various cellular processes, including the regulation of ion channels, the production of adenosine, and the regulation of inflammation. Its involvement in these processes makes it an attractive target for the development of new therapeutic strategies for various diseases.

As a biomarker, NDUFS7 can be used to diagnose and monitor the progression of certain diseases. For example, changes in the levels of NDUFS7 have been observed in various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. These changes in NDUFS7 levels can be used as a diagnostic or monitoring tool for these diseases, providing valuable information for the treatment and management of these conditions.

Conclusion

In conclusion, NDUFS7 is a protein component of the mitochondrial respiratory chain that plays a crucial role in various cellular processes. Its potential as a drug target and biomarker makes it an attractive target for the development of new therapeutic strategies for various diseases. Further research is needed to fully understand the role of NDUFS7 in cellular processes and its potential as a therapeutic target.

Protein Name: NADH:ubiquinone Oxidoreductase Core Subunit S7

Functions: Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:17275378). Essential for the catalytic activity of complex I (PubMed:17275378)

The "NDUFS7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFS7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets